← Eichor
Condition: Autoimmune Hemolytic Anemia Aiha Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Autoimmune Hemolytic Anemia Aiha

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

UCAR T-cell Therapy Targeting CD19/BCMA in Relapsed/Refractory Autoimmune Hemolytic Anemia
EARLY_Phase 1 · 1 location(s) · The Second Hospital of Anhui Medical University · NCT07530380Orelabrutinib in the Treatment of Relapsed/Refractory AIHA
Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT07453368A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus
EARLY_Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06653556OM336 in Autoimmune Cytopenias
Phase 1 · 3 location(s) · Lakefront Biotherapeutics West LLC · NCT07083960National Longitudinal Cohort of Hematological Diseases
Phase N/A · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04645199National Longitudinal Cohort of Hematological Diseases- Autoimmune Hemolytic Anemia
Phase N/A · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07019038A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-p
EARLY_Phase 1 · 2 location(s) · Grit Biotechnology · NCT07205315Sirolimus in the Treatment of Refractory/Relapsed wAIHA
NA · 1 location(s) · Peking Union Medical College Hospital · NCT05925023Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL
Phase 2 · 3 location(s) · Gruppo Italiano Malattie EMatologiche dell'Adulto · NCT05694312Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for
EARLY_Phase 1 · 1 location(s) · Circunited BioPharma (Shenzhen) Co., Ltd. · NCT07629596UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases
EARLY_Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT07441525Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic
Phase N/A · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT05931718CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy.
Phase 1 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06733610
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.